Skip to main content
. 2017 Mar 7;8:320. doi: 10.3389/fpls.2017.00320

Table 1.

The labeling strategy used for iTRAQ.

Labeling Set 1 Set 2
Treatment Protein content (mg g−1 Fw) Treatment Protein content (mg g−1 Fw)
113 MC1 25.33 MC1 25.33
114 MC2 24.87 FC1 24.47
115 MC3 24.01 FC2 26.15
116 MU1 23.05 FC3 25.50
117 MU2 25.73 FU1 26.18
118 MU3 26.27 FU2 24.75
119 FU3 25.44

MC, males under low UV-B radiation; FC, females under low UV-B radiation; MU, males under high UV-B radiation; FU, males under high UV-B radiation; Fw, fresh weight.

HHS Vulnerability Disclosure